{"id":837027,"date":"2025-04-14T11:01:11","date_gmt":"2025-04-14T15:01:11","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/final-deadline-today-for-the-intellia-therapeutics-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-ntla\/"},"modified":"2025-04-14T11:01:11","modified_gmt":"2025-04-14T15:01:11","slug":"final-deadline-today-for-the-intellia-therapeutics-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-ntla","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/final-deadline-today-for-the-intellia-therapeutics-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-ntla\/","title":{"rendered":"Final Deadline Today for the Intellia Therapeutics, Inc. Securities Lawsuit – Contact the DJS Law Group to Discuss Your Rights – NTLA"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n
\n LOS ANGELES<\/span>
\n <\/span>, April 14, 2025<\/span><\/span> \/PRNewswire\/ — The DJS Law Group<\/a>\u00a0reminds investors of a class action lawsuit against Intellia Therapeutics (“Intellia” or “the Company”) (NASDAQ: NTLA) for violations of the federal securities laws.<\/p>\n

\n

\n
\n \"DJS
\n <\/a>\n <\/p>\n<\/p><\/div>\n

Shareholders who purchased the Company’s securities between July 30, 2024<\/span> and January 8, 2025<\/span>, inclusive (the “Class Period”), are encouraged to contact the firm before April 14<\/span>, 2025.\u00a0\u00a0<\/p>\n

\n CASE DETAILS:<\/b>\u00a0\u00a0According to the Complaint, Intellia made false and misleading statements to the market when it allegedly<\/span> gave investors the false impression that it had reliable information about the development and marketing of NTLA-3001. The Company’s reports on timelines including future studies of its drug were not sustainable or viable due to expensive and inefficient delivery methods. The Company was not capable of providing patients with timely doses of NTLA-3001 or even to maintain full staffing<\/p>\n

If you are a shareholder who suffered a loss,\u00a0contact us to participate<\/a>.<\/p>\n

\n WHY DJS LAW GROUP?<\/b>\u00a0DJS Law Group’s primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic\/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results.<\/p>\n

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.<\/p>\n

\n CONTACT:<\/b>\n <\/p>\n

\n David J. Schwartz<\/span>\n <\/p>\n

DJS Law Group<\/p>\n

274 White Plains Road, Suite 1<\/p>\n

\u00a0Eastchester, NY 10709<\/p>\n

Phone: 914-206-9742<\/p>\n

Email:\u00a0David@djslawllp.com<\/a><\/p>\n

\n \"Cision\" View original content to download multimedia:https:\/\/www.prnewswire.com\/news-releases\/final-deadline-today-for-the-intellia-therapeutics-inc-securities-lawsuit—contact-the-djs-law-group-to-discuss-your-rights–ntla-302427234.html<\/a><\/p>\n

SOURCE DJS Law Group LLP<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire LOS ANGELES , April 14, 2025 \/PRNewswire\/ — The DJS Law Group\u00a0reminds investors of a class action lawsuit against Intellia Therapeutics (“Intellia” or “the Company”) (NASDAQ: NTLA) for violations of the federal securities laws. Shareholders who purchased the Company’s securities between July 30, 2024 and January 8, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before April 14, 2025.\u00a0\u00a0 CASE DETAILS:\u00a0\u00a0According to the Complaint, Intellia made false and misleading statements to the market when it allegedly gave investors the false impression that it had reliable information about the development and marketing of NTLA-3001. The Company’s reports on timelines including future studies of its drug were not sustainable or viable due to expensive and inefficient delivery … <\/p>\n

Continue reading “Final Deadline Today for the Intellia Therapeutics, Inc. Securities Lawsuit – Contact the DJS Law Group to Discuss Your Rights – NTLA”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-837027","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nFinal Deadline Today for the Intellia Therapeutics, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - NTLA - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/final-deadline-today-for-the-intellia-therapeutics-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-ntla\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Final Deadline Today for the Intellia Therapeutics, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - NTLA - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire LOS ANGELES , April 14, 2025 \/PRNewswire\/ — The DJS Law Group\u00a0reminds investors of a class action lawsuit against Intellia Therapeutics (“Intellia” or “the Company”) (NASDAQ: NTLA) for violations of the federal securities laws. Shareholders who purchased the Company’s securities between July 30, 2024 and January 8, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before April 14, 2025.\u00a0\u00a0 CASE DETAILS:\u00a0\u00a0According to the Complaint, Intellia made false and misleading statements to the market when it allegedly gave investors the false impression that it had reliable information about the development and marketing of NTLA-3001. The Company’s reports on timelines including future studies of its drug were not sustainable or viable due to expensive and inefficient delivery … Continue reading "Final Deadline Today for the Intellia Therapeutics, Inc. Securities Lawsuit – Contact the DJS Law Group to Discuss Your Rights – NTLA"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/final-deadline-today-for-the-intellia-therapeutics-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-ntla\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-14T15:01:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/2663498\/DJS_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/final-deadline-today-for-the-intellia-therapeutics-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-ntla\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/final-deadline-today-for-the-intellia-therapeutics-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-ntla\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Final Deadline Today for the Intellia Therapeutics, Inc. Securities Lawsuit – Contact the DJS Law Group to Discuss Your Rights – NTLA\",\"datePublished\":\"2025-04-14T15:01:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/final-deadline-today-for-the-intellia-therapeutics-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-ntla\\\/\"},\"wordCount\":296,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/final-deadline-today-for-the-intellia-therapeutics-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-ntla\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2663498\\\/DJS_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/final-deadline-today-for-the-intellia-therapeutics-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-ntla\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/final-deadline-today-for-the-intellia-therapeutics-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-ntla\\\/\",\"name\":\"Final Deadline Today for the Intellia Therapeutics, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - NTLA - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/final-deadline-today-for-the-intellia-therapeutics-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-ntla\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/final-deadline-today-for-the-intellia-therapeutics-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-ntla\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2663498\\\/DJS_Logo.jpg\",\"datePublished\":\"2025-04-14T15:01:11+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/final-deadline-today-for-the-intellia-therapeutics-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-ntla\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/final-deadline-today-for-the-intellia-therapeutics-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-ntla\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/final-deadline-today-for-the-intellia-therapeutics-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-ntla\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2663498\\\/DJS_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2663498\\\/DJS_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/final-deadline-today-for-the-intellia-therapeutics-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-ntla\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Final Deadline Today for the Intellia Therapeutics, Inc. Securities Lawsuit – Contact the DJS Law Group to Discuss Your Rights – NTLA\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Final Deadline Today for the Intellia Therapeutics, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - NTLA - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/final-deadline-today-for-the-intellia-therapeutics-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-ntla\/","og_locale":"en_US","og_type":"article","og_title":"Final Deadline Today for the Intellia Therapeutics, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - NTLA - Market Newsdesk","og_description":"PR Newswire LOS ANGELES , April 14, 2025 \/PRNewswire\/ — The DJS Law Group\u00a0reminds investors of a class action lawsuit against Intellia Therapeutics (“Intellia” or “the Company”) (NASDAQ: NTLA) for violations of the federal securities laws. Shareholders who purchased the Company’s securities between July 30, 2024 and January 8, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before April 14, 2025.\u00a0\u00a0 CASE DETAILS:\u00a0\u00a0According to the Complaint, Intellia made false and misleading statements to the market when it allegedly gave investors the false impression that it had reliable information about the development and marketing of NTLA-3001. The Company’s reports on timelines including future studies of its drug were not sustainable or viable due to expensive and inefficient delivery … Continue reading \"Final Deadline Today for the Intellia Therapeutics, Inc. Securities Lawsuit – Contact the DJS Law Group to Discuss Your Rights – NTLA\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/final-deadline-today-for-the-intellia-therapeutics-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-ntla\/","og_site_name":"Market Newsdesk","article_published_time":"2025-04-14T15:01:11+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/2663498\/DJS_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/final-deadline-today-for-the-intellia-therapeutics-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-ntla\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/final-deadline-today-for-the-intellia-therapeutics-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-ntla\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Final Deadline Today for the Intellia Therapeutics, Inc. Securities Lawsuit – Contact the DJS Law Group to Discuss Your Rights – NTLA","datePublished":"2025-04-14T15:01:11+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/final-deadline-today-for-the-intellia-therapeutics-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-ntla\/"},"wordCount":296,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/final-deadline-today-for-the-intellia-therapeutics-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-ntla\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2663498\/DJS_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/final-deadline-today-for-the-intellia-therapeutics-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-ntla\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/final-deadline-today-for-the-intellia-therapeutics-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-ntla\/","name":"Final Deadline Today for the Intellia Therapeutics, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - NTLA - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/final-deadline-today-for-the-intellia-therapeutics-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-ntla\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/final-deadline-today-for-the-intellia-therapeutics-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-ntla\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2663498\/DJS_Logo.jpg","datePublished":"2025-04-14T15:01:11+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/final-deadline-today-for-the-intellia-therapeutics-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-ntla\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/final-deadline-today-for-the-intellia-therapeutics-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-ntla\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/final-deadline-today-for-the-intellia-therapeutics-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-ntla\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/2663498\/DJS_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/2663498\/DJS_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/final-deadline-today-for-the-intellia-therapeutics-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-ntla\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Final Deadline Today for the Intellia Therapeutics, Inc. Securities Lawsuit – Contact the DJS Law Group to Discuss Your Rights – NTLA"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/837027","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=837027"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/837027\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=837027"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=837027"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=837027"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}